Treatment and Control of Atopic Dermatitis With 0.03% Tacrolimus Ointment
Status:
Completed
Trial end date:
2005-11-01
Target enrollment:
Participant gender:
Summary
A long-term 0.03% tacrolimus ointment based regimen comprising of up to 6 weeks of initial
twice daily treatment and subsequent twice weekly prophylactic application can effectively
treat active lesions of atopic dermatitis, and prevent, delay, and reduce flares.